aluates Reports

$ 0.0

Automative

Global Investigational New Drug Contract Development and Manufacturing Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-25E9484

Global Investigational New Drug Contract Development and Manufacturing Market Research Report 2022

BUY CHAPTERS

Global Investigational New Drug Contract Development and Manufacturing Market Research Report 2025

Code: QYRE-Auto-25E9484

Report

March 2025

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Covance

Charles River Laboratories Inc.

Cambrex Corporation

IQVIA Holdings, Inc.

Syneos Health

Lonza

Catalent

Recipharm

Siegfried Holding AG

Thermo Fisher Scientific Inc

Investigational New Drug Contract Development and Manufacturing Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Investigational New Drug Contract Development and Manufacturing Market

The global market for Investigational New Drug Contract Development and Manufacturing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Investigational New Drug Contract Development and Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Investigational New Drug Contract Development and Manufacturing.

The Investigational New Drug Contract Development and Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Investigational New Drug Contract Development and Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Investigational New Drug Contract Development and Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Investigational New Drug Contract Development and Manufacturing Market Report

Report Metric	Details
Report Name	Investigational New Drug Contract Development and Manufacturing Market
CAGR	5%
Segment by Type	Contract Development Contract Manufacturing
Segment by Application	Pharmaceutical Biotechnology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Covance Inc., Charles River Laboratories Inc., Cambrex Corporation, IQVIA Holdings Inc., Syneos Health, Lonza, Catalent, Recipharm AB, Siegfried Holding AG, Thermo Fisher Scientific Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Investigational New Drug Contract Development and Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Investigational New Drug Contract Development and Manufacturing Market report?

Ans: The main players in the Investigational New Drug Contract Development and Manufacturing Market are Covance Inc., Charles River Laboratories Inc., Cambrex Corporation, IQVIA Holdings Inc., Syneos Health, Lonza, Catalent, Recipharm AB, Siegfried Holding AG, Thermo Fisher Scientific Inc.

What are the Application segmentation covered in the Investigational New Drug Contract Development and Manufacturing Market report?

Ans: The Applications covered in the Investigational New Drug Contract Development and Manufacturing Market report are Pharmaceutical, Biotechnology, Others

What are the Type segmentation covered in the Investigational New Drug Contract Development and Manufacturing Market report?

Ans: The Types covered in the Investigational New Drug Contract Development and Manufacturing Market report are Contract Development, Contract Manufacturing

Recommended Reports

Pharmaceutical CDMO & CRO

Drug Discovery & Testing

Diagnostics & Monitoring

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Investigational New Drug Contract Development and Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Contract Development

1.2.3 Contract Manufacturing

1.3 Market by Application

1.3.1 Global Investigational New Drug Contract Development and Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical

1.3.3 Biotechnology

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Investigational New Drug Contract Development and Manufacturing Market Perspective (2020-2031)

2.2 Global Investigational New Drug Contract Development and Manufacturing Growth Trends by Region

2.2.1 Global Investigational New Drug Contract Development and Manufacturing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Investigational New Drug Contract Development and Manufacturing Historic Market Size by Region (2020-2025)

2.2.3 Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Region (2026-2031)

2.3 Investigational New Drug Contract Development and Manufacturing Market Dynamics

2.3.1 Investigational New Drug Contract Development and Manufacturing Industry Trends

2.3.2 Investigational New Drug Contract Development and Manufacturing Market Drivers

2.3.3 Investigational New Drug Contract Development and Manufacturing Market Challenges

2.3.4 Investigational New Drug Contract Development and Manufacturing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Investigational New Drug Contract Development and Manufacturing Players by Revenue

3.1.1 Global Top Investigational New Drug Contract Development and Manufacturing Players by Revenue (2020-2025)

3.1.2 Global Investigational New Drug Contract Development and Manufacturing Revenue Market Share by Players (2020-2025)

3.2 Global Investigational New Drug Contract Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Investigational New Drug Contract Development and Manufacturing Revenue

3.4 Global Investigational New Drug Contract Development and Manufacturing Market Concentration Ratio

3.4.1 Global Investigational New Drug Contract Development and Manufacturing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Investigational New Drug Contract Development and Manufacturing Revenue in 2024

3.5 Global Key Players of Investigational New Drug Contract Development and Manufacturing Head office and Area Served

3.6 Global Key Players of Investigational New Drug Contract Development and Manufacturing, Product and Application

3.7 Global Key Players of Investigational New Drug Contract Development and Manufacturing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Investigational New Drug Contract Development and Manufacturing Breakdown Data by Type

4.1 Global Investigational New Drug Contract Development and Manufacturing Historic Market Size by Type (2020-2025)

4.2 Global Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Type (2026-2031)

5 Investigational New Drug Contract Development and Manufacturing Breakdown Data by Application

5.1 Global Investigational New Drug Contract Development and Manufacturing Historic Market Size by Application (2020-2025)

5.2 Global Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Investigational New Drug Contract Development and Manufacturing Market Size (2020-2031)

6.2 North America Investigational New Drug Contract Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2020-2025)

6.4 North America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Investigational New Drug Contract Development and Manufacturing Market Size (2020-2031)

7.2 Europe Investigational New Drug Contract Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Investigational New Drug Contract Development and Manufacturing Market Size by Country (2020-2025)

7.4 Europe Investigational New Drug Contract Development and Manufacturing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size (2020-2031)

8.2 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Region (2020-2025)

8.4 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Investigational New Drug Contract Development and Manufacturing Market Size (2020-2031)

9.2 Latin America Investigational New Drug Contract Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2020-2025)

9.4 Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size (2020-2031)

10.2 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Country (2020-2025)

10.4 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Covance Inc.

11.1.1 Covance Inc. Company Details

11.1.2 Covance Inc. Business Overview

11.1.3 Covance Inc. Investigational New Drug Contract Development and Manufacturing Introduction

11.1.4 Covance Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

11.1.5 Covance Inc. Recent Development

11.2 Charles River Laboratories Inc.

11.2.1 Charles River Laboratories Inc. Company Details

11.2.2 Charles River Laboratories Inc. Business Overview

11.2.3 Charles River Laboratories Inc. Investigational New Drug Contract Development and Manufacturing Introduction

11.2.4 Charles River Laboratories Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

11.2.5 Charles River Laboratories Inc. Recent Development

11.3 Cambrex Corporation

11.3.1 Cambrex Corporation Company Details

11.3.2 Cambrex Corporation Business Overview

11.3.3 Cambrex Corporation Investigational New Drug Contract Development and Manufacturing Introduction

11.3.4 Cambrex Corporation Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

11.3.5 Cambrex Corporation Recent Development

11.4 IQVIA Holdings Inc.

11.4.1 IQVIA Holdings Inc. Company Details

11.4.2 IQVIA Holdings Inc. Business Overview

11.4.3 IQVIA Holdings Inc. Investigational New Drug Contract Development and Manufacturing Introduction

11.4.4 IQVIA Holdings Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

11.4.5 IQVIA Holdings Inc. Recent Development

11.5 Syneos Health

11.5.1 Syneos Health Company Details

11.5.2 Syneos Health Business Overview

11.5.3 Syneos Health Investigational New Drug Contract Development and Manufacturing Introduction

11.5.4 Syneos Health Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

11.5.5 Syneos Health Recent Development

11.6 Lonza

11.6.1 Lonza Company Details

11.6.2 Lonza Business Overview

11.6.3 Lonza Investigational New Drug Contract Development and Manufacturing Introduction

11.6.4 Lonza Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

11.6.5 Lonza Recent Development

11.7 Catalent

11.7.1 Catalent Company Details

11.7.2 Catalent Business Overview

11.7.3 Catalent Investigational New Drug Contract Development and Manufacturing Introduction

11.7.4 Catalent Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

11.7.5 Catalent Recent Development

11.8 Recipharm AB

11.8.1 Recipharm AB Company Details

11.8.2 Recipharm AB Business Overview

11.8.3 Recipharm AB Investigational New Drug Contract Development and Manufacturing Introduction

11.8.4 Recipharm AB Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

11.8.5 Recipharm AB Recent Development

11.9 Siegfried Holding AG

11.9.1 Siegfried Holding AG Company Details

11.9.2 Siegfried Holding AG Business Overview

11.9.3 Siegfried Holding AG Investigational New Drug Contract Development and Manufacturing Introduction

11.9.4 Siegfried Holding AG Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

11.9.5 Siegfried Holding AG Recent Development

11.10 Thermo Fisher Scientific Inc.

11.10.1 Thermo Fisher Scientific Inc. Company Details

11.10.2 Thermo Fisher Scientific Inc. Business Overview

11.10.3 Thermo Fisher Scientific Inc. Investigational New Drug Contract Development and Manufacturing Introduction

11.10.4 Thermo Fisher Scientific Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

11.10.5 Thermo Fisher Scientific Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Covance

Charles River Laboratories Inc.

Cambrex Corporation

IQVIA Holdings, Inc.

Syneos Health

Lonza

Catalent

Recipharm

Siegfried Holding AG

Thermo Fisher Scientific Inc

List of Tables

Table 1. Global Investigational New Drug Contract Development and Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Contract Development

Table 3. Key Players of Contract Manufacturing

Table 4. Global Investigational New Drug Contract Development and Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Investigational New Drug Contract Development and Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Investigational New Drug Contract Development and Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Investigational New Drug Contract Development and Manufacturing Market Share by Region (2020-2025)

Table 8. Global Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Investigational New Drug Contract Development and Manufacturing Market Share by Region (2026-2031)

Table 10. Investigational New Drug Contract Development and Manufacturing Market Trends

Table 11. Investigational New Drug Contract Development and Manufacturing Market Drivers

Table 12. Investigational New Drug Contract Development and Manufacturing Market Challenges

Table 13. Investigational New Drug Contract Development and Manufacturing Market Restraints

Table 14. Global Investigational New Drug Contract Development and Manufacturing Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Investigational New Drug Contract Development and Manufacturing Market Share by Players (2020-2025)

Table 16. Global Top Investigational New Drug Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Investigational New Drug Contract Development and Manufacturing as of 2024)

Table 17. Ranking of Global Top Investigational New Drug Contract Development and Manufacturing Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Investigational New Drug Contract Development and Manufacturing Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Investigational New Drug Contract Development and Manufacturing, Headquarters and Area Served

Table 20. Global Key Players of Investigational New Drug Contract Development and Manufacturing, Product and Application

Table 21. Global Key Players of Investigational New Drug Contract Development and Manufacturing, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Investigational New Drug Contract Development and Manufacturing Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Investigational New Drug Contract Development and Manufacturing Revenue Market Share by Type (2020-2025)

Table 25. Global Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Investigational New Drug Contract Development and Manufacturing Revenue Market Share by Type (2026-2031)

Table 27. Global Investigational New Drug Contract Development and Manufacturing Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Investigational New Drug Contract Development and Manufacturing Revenue Market Share by Application (2020-2025)

Table 29. Global Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Investigational New Drug Contract Development and Manufacturing Revenue Market Share by Application (2026-2031)

Table 31. North America Investigational New Drug Contract Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Investigational New Drug Contract Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Investigational New Drug Contract Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Investigational New Drug Contract Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Investigational New Drug Contract Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 46. Covance Inc. Company Details

Table 47. Covance Inc. Business Overview

Table 48. Covance Inc. Investigational New Drug Contract Development and Manufacturing Product

Table 49. Covance Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 50. Covance Inc. Recent Development

Table 51. Charles River Laboratories Inc. Company Details

Table 52. Charles River Laboratories Inc. Business Overview

Table 53. Charles River Laboratories Inc. Investigational New Drug Contract Development and Manufacturing Product

Table 54. Charles River Laboratories Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 55. Charles River Laboratories Inc. Recent Development

Table 56. Cambrex Corporation Company Details

Table 57. Cambrex Corporation Business Overview

Table 58. Cambrex Corporation Investigational New Drug Contract Development and Manufacturing Product

Table 59. Cambrex Corporation Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 60. Cambrex Corporation Recent Development

Table 61. IQVIA Holdings Inc. Company Details

Table 62. IQVIA Holdings Inc. Business Overview

Table 63. IQVIA Holdings Inc. Investigational New Drug Contract Development and Manufacturing Product

Table 64. IQVIA Holdings Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 65. IQVIA Holdings Inc. Recent Development

Table 66. Syneos Health Company Details

Table 67. Syneos Health Business Overview

Table 68. Syneos Health Investigational New Drug Contract Development and Manufacturing Product

Table 69. Syneos Health Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 70. Syneos Health Recent Development

Table 71. Lonza Company Details

Table 72. Lonza Business Overview

Table 73. Lonza Investigational New Drug Contract Development and Manufacturing Product

Table 74. Lonza Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 75. Lonza Recent Development

Table 76. Catalent Company Details

Table 77. Catalent Business Overview

Table 78. Catalent Investigational New Drug Contract Development and Manufacturing Product

Table 79. Catalent Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 80. Catalent Recent Development

Table 81. Recipharm AB Company Details

Table 82. Recipharm AB Business Overview

Table 83. Recipharm AB Investigational New Drug Contract Development and Manufacturing Product

Table 84. Recipharm AB Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 85. Recipharm AB Recent Development

Table 86. Siegfried Holding AG Company Details

Table 87. Siegfried Holding AG Business Overview

Table 88. Siegfried Holding AG Investigational New Drug Contract Development and Manufacturing Product

Table 89. Siegfried Holding AG Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 90. Siegfried Holding AG Recent Development

Table 91. Thermo Fisher Scientific Inc. Company Details

Table 92. Thermo Fisher Scientific Inc. Business Overview

Table 93. Thermo Fisher Scientific Inc. Investigational New Drug Contract Development and Manufacturing Product

Table 94. Thermo Fisher Scientific Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2020-2025) & (US$ Million)

Table 95. Thermo Fisher Scientific Inc. Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Investigational New Drug Contract Development and Manufacturing Picture

Figure 2. Global Investigational New Drug Contract Development and Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Investigational New Drug Contract Development and Manufacturing Market Share by Type: 2024 VS 2031

Figure 4. Contract Development Features

Figure 5. Contract Manufacturing Features

Figure 6. Global Investigational New Drug Contract Development and Manufacturing Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Investigational New Drug Contract Development and Manufacturing Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceutical Case Studies

Figure 9. Biotechnology Case Studies

Figure 10. Others Case Studies

Figure 11. Investigational New Drug Contract Development and Manufacturing Report Years Considered

Figure 12. Global Investigational New Drug Contract Development and Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Investigational New Drug Contract Development and Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Investigational New Drug Contract Development and Manufacturing Market Share by Region: 2024 VS 2031

Figure 15. Global Investigational New Drug Contract Development and Manufacturing Market Share by Players in 2024

Figure 16. Global Top Investigational New Drug Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Investigational New Drug Contract Development and Manufacturing as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Investigational New Drug Contract Development and Manufacturing Revenue in 2024

Figure 18. North America Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Investigational New Drug Contract Development and Manufacturing Market Share by Country (2020-2031)

Figure 20. United States Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Investigational New Drug Contract Development and Manufacturing Market Share by Country (2020-2031)

Figure 24. Germany Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Share by Region (2020-2031)

Figure 32. China Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Investigational New Drug Contract Development and Manufacturing Market Share by Country (2020-2031)

Figure 40. Mexico Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Share by Country (2020-2031)

Figure 44. Turkey Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Investigational New Drug Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Covance Inc. Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

Figure 48. Charles River Laboratories Inc. Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

Figure 49. Cambrex Corporation Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

Figure 50. IQVIA Holdings Inc. Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

Figure 51. Syneos Health Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

Figure 52. Lonza Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

Figure 53. Catalent Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

Figure 54. Recipharm AB Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

Figure 55. Siegfried Holding AG Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

Figure 56. Thermo Fisher Scientific Inc. Revenue Growth Rate in Investigational New Drug Contract Development and Manufacturing Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT